Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Neoplasms of the CNS

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 102 articles: HTML format Text format

Single Articles

May 2012
1. SEE WL , Tan IL, Mukherjee J, Nicolaides T, et al
   Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
2. HU YL , Delay M, Jahangiri A, Molinaro AM, et al
   Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. YEO CW , Ng FS, Chai C, Tan J, et al
   Parkin pathway activation mitigates glioma cell proliferation and predicts patient survival.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. HUANG P , Rani MR, Ahluwalia MS, Bae E, et al
   Endothelial Expression of TNF Receptor-1 Generates a Proapoptotic Signal Inhibited by Integrin alpha6beta1 in Glioblastoma.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. DOLOFF JC , Waxman DJ
   VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity-induced tumor regression.
   Cancer Res. 2012;72:1103-15.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
6. 
   Correction: Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion.
   Cancer Res. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
7. LITTLE SE , Popov S, Jury A, Bax DA, et al
   Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
8. HASELEY A , Boone S, Wojton J, Yu L, et al
   Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. FITZGERALD DP , Subramanian P, Deshpande M, Graves C, et al
   Opposing Effects of Pigment Epithelium-Derived Factor on Breast Cancer Cell versus Neuronal Survival: Implication for Brain Metastasis and Metastasis-Induced Brain Damage.
   Cancer Res. 2012;72:144-153.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
10. JIN SG , Jiang Y, Qiu R, Rauch TA, et al
    5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations.
    Cancer Res. 2011;71:7360-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. CHEN DY , Lee Y, Van Tine BA, Searleman AC, et al
    A Pharmacological Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. WALKER EJ , Zhang C, Castelo-Branco P, Hawkins C, et al
    Monoallelic Expression Determines Oncogenic Progression and Outcome in Benign and Malignant Brain Tumors.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. EBERLIN LS , Norton I, Dill AL, Golby AJ, et al
    Classifying human brain tumors by lipid imaging with mass spectrometry.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
14. SORENSEN AG , Emblem KE, Polaskova P, Jennings D, et al
    Increased Survival of Glioblastoma Patients who Respond to Anti-angiogenic Therapy with Elevated Blood Perfusion.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. SENGUPTA R , Dubuc A, Ward S, Yang L, et al
    CXCR4 activation defines a new subgroup of Sonic Hedgehog driven Medulloblastoma.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
16. SHETE SS , Lau CC, Houlston RS, Claus EB, et al
    Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. MENGXIAN Z , Kleber S, Roehrich M, Timke C, et al
    Blockade of TGF-beta signaling by the TGF{beta}R-I kinase Inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. CHO J , Pastorino S, Zeng Q, Xu X, et al
    Glioblastoma-derived Epidermal Growth Factor Receptor (EGFR) carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. PULVIRENTI T , Van Der Heijden M, Droms LA, Huse JT, et al
    Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. ACQUAVIVA J , Jun HJ, Lessard J, Ruiz R, et al
    Chronic Activation of Wild Type Epidermal Growth Factor Receptor and Loss of Cdkn2a Cause Mouse Glioblastoma Formation.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. JIN X , Yin J, Kim SH, Sohn YW, et al
    EGFR-AKT-SMAD signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
22. SQUATRITO M , Holland EC
    DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance.
    Cancer Res. 2011;71:5945-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. OLIN MR , Andersen BM, Litterman AJ, Grogan PT, et al
    Oxygen is a Master Regulator of the Immunogenicity of Primary Human Glioma Cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. SWANSON KR , Rockne RC, Claridge J, Chaplain MA, et al
    Quantifying the role of angiogenesis in malignant progression of gliomas: In silico modeling integrates imaging and histology.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SOROCEANU L , Matlaf L, Bezrookove V, Harkins L, et al
    Human Cytomegalovirus US28 Found in Glioblastoma Promotes an Invasive and Angiogenic Phenotype.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
26. 
    Correction: ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*-Mediated Suppression of SOX2.
    Cancer Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
27. BURDEN-GULLEY SM , Qutaish MQ, Sullivant KE, Lu H, et al
    Novel Cryo-Imaging of the Glioma Tumor Microenvironment Reveals Migration and Dispersal Pathways in Vivid Three-Dimensional Detail.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. TCHAICHA JH , Reyes SB, Shin J, Hossain MG, et al
    Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by {beta}8 integrin.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. LU W , Melancon MP, Xiong C, Huang Q, et al
    Effects of photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic mouse xenograft model of glioma.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. LEE SG , Kim K, Kegelman TP, Dash R, et al
    AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. WANSHURA LE , Galvin KE, Ye H, Fernandez-Zapico ME, et al
    Sequential activation of Snail1 and N-Myc modulates sonic hedgehog-induced transformation of neural cells.
    Cancer Res. 2011;71:5336-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
32. ZHU T , Costello MA, Talsma CE, Flack CG, et al
    Endothelial cells create a stem cell niche in glioblastoma by providing Notch ligands that nurture self-renewal of cancer stem-like cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. FOTOVATI A , Abu-Ali S, Wang PS, Deleyrolle LP, et al
    YB-1 bridges neural stem cells and brain-tumor initiating cells via its roles in differentiation and cell growth.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ZHU D , Hunter SB, Vertino PM, Van Meir EG, et al
    Overexpression of MBD2 in Glioblastoma Maintains Epigenetic Silencing and Inhibits the Anti-Angiogenic Function of the Tumor Suppressor Gene BAI1.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
35. WILLIAMS SP , Nowicki MO, Liu F, Press R, et al
    Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. CHIU WT , Lee HT, Huang FJ, Aldape KD, et al
    Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by Stat3 inhibition.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
37. BONAVIA R , Inda MD, Cavenee WK, Furnari FB, et al
    Heterogeneity Maintenance in Glioblastoma: A Social Network.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. BHOOPATHI P , Chetty C, Dontula R, Gujrati M, et al
    SPARC Stimulates Neuronal Differentiation of Medulloblastoma Cells via the Notch1/Signal Transducer and Activator of Transcription 3 (STAT3) Pathway.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. GOLAN-GERSTL R , Shilo A, Cohen M, Suh SS, et al
    Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. MASICA DL , Karchin R
    Correlation of Somatic Mutation and Expression Identifies Genes Important in Human Glioblastoma Progression and Survival.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. JEON HM , Sohn YW, Oh SY, Kim SH, et al
    ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*-Mediated Suppression of SOX2.
    Cancer Res. 2011;71:3410-21.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
42. AGERHOLM-LARSEN B , Iversen HK, Ibsen P, Moller JM, et al
    Preclinical validation of electrochemotherapy as an effective treatment for brain tumors.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. ENDERSBY R , Zhu X, Hay N, Ellison DW, et al
    Non-redundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. KIM H , Catana C, Ratai EM, Andronesi OC, et al
    Serial MR Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. GABRIELY G , Yi M, Narayan RS, Niers JM, et al
    Human glioma growth is controlled by microRNA-10b.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. LOPEZ KA , Tannenbaum AM, Assanah M, Linskey K, et al
    Convection-enhanced delivery of topotecan into a PDGF-driven model of glioblastoma prolongs survival, ablates tumor initiating cells and recruited glial progenitors.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
47. GRZMIL M , Morin P Jr, Lino MM, Merlo A, et al
    MAP Kinase-Interacting Kinase 1 Regulates SMAD2-Dependent TGF-{beta} Signaling Pathway in Human Glioblastoma.
    Cancer Res. 2011;71:2392-402.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. GOELLNER EM , Grimme B, Brown AR, Lin YC, et al
    Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair.
    Cancer Res. 2011;71:2308-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. KIM TM , Huang W, Park R, Park PJ, et al
    A developmental taxonomy of glioblastoma defined and maintained by microRNAs.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. JIN X , Jeon HY, Joo KM, Kim JK, et al
    Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
51. FUJITA M , Kohanbash G, Fellows-Mayle W, Hamilton RL, et al
    COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. GRINSHTEIN N , Datti A, Fujitani M, Uehling D, et al
    Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells.
    Cancer Res. 2011;71:1385-95.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
53. ZHANG L , Sullivan PS, Goodman JC, Gunaratne PH, et al
    MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting Heparanase.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. MAROTTA D , Karar J, Jenkins WT, Kumanova M, et al
    In Vivo Profiling of Hypoxic Gene Expression in Gliomas Using the Hypoxia Marker EF5 and Laser-capture Microdissection.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. MENGHI F , Jacques TS, Barenco M, Schwalbe EC, et al
    Genome-wide analysis of alternative splicing in medulloblastoma identifies splicing patterns characteristic of normal cerebellar development.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. SHAZEEB MS , Sotak CH, Deleo M 3rd, Bogdanov AA, et al
    Targeted signal amplifying enzymes enhance magnetic resonance imaging of EGRF expression in an orthotopic model of human glioma.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. PIERFELICE TJ , Schreck KC, Dang L, Asnaghi L, et al
    Notch3 Activation Promotes Invasive Glioma Formation in a Tissue Site-Specific Manner.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. DIJKGRAAF GJ , Alicke B, Weinmann L, Januario T, et al
    Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance.
    Cancer Res. 2011;71:435-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. DI TOMASO E , Snuderl M, Kamoun WS, Duda DG, et al
    Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of "Rebound" Revascularization as Mode of Escape.
    Cancer Res. 2011;71:19-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
60. MURAGUCHI T , Tanaka S, Yamada D, Tamase A, et al
    NKX2.2 suppresses self renewal of glioma-initiating cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. LEE J , Borboa AK, Chun HB, Baird A, et al
    Conditional Deletion of the Focal Adhesion Kinase FAK Alters Remodeling of the Blood-Brain Barrier in Glioma.
    Cancer Res. 2010;70:10131-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. IVLIEV AE , 't Hoen PA, Sergeeva MG
    Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.
    Cancer Res. 2010;70:10060-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
63. KIM CK , Nguyen TL, Joo KM, Nam DH, et al
    Negative Regulation of p53 by the Long Isoform of ErbB3 Binding Protein Ebp1 in Brain Tumors.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. BAGCI-ONDER T , Wakimoto H, Anderegg M, Cameron C, et al
    A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell delivered TRAIL in experimental glioma models.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. WAN Y , Kim YT, Li N, Cho SK, et al
    Surface-immobilized aptamers for cancer cell isolation and microscopic cytology.
    Cancer Res. 2010;70:9371-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. SELTZER MJ , Bennett BD, Joshi AD, Gao P, et al
    Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
67. YIN JJ , Zhang L, Munasinghe J, Linnoila RI, et al
    Cediranib/AZD2171 Inhibits Bone and Brain Metastasis in a Preclinical Model of Advanced Prostate Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. PRESTEGARDEN L , Enger PO
    Cancer Stem Cells in the Central Nervous System - A Critical Review.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. GASPAR N , Marshall L, Perryman L, Bax DA, et al
    MGMT-INDEPENDENT TEMOZOLOMIDE RESISTANCE IN PAEDIATRIC GLIOBLASTOMA CELLS ASSOCIATED WITH A PI3-KINASE-MEDIATED HOX / STEM CELL GENE SIGNATURE.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. TRAENKA C , Remke M, Korshunov A, Bender S, et al
    Role of LIM and SH3 Protein 1 (LASP1) in the Metastatic Dissemination of Medulloblastoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
71. ZHOU L , Picard D, Ra YS, Li M, et al
    Silencing of Thrombospondin-1 Is Critical for Myc-Induced Metastatic Phenotypes in Medulloblastoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. MONLEON D , Morales JM, Gonzalez-Segura A, Gonzalez-Darder J, et al
    Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. MAZZOLENI S , Politi LS, Pala M, Cominelli M, et al
    Epidermal Growth Factor Receptor Expression Identifies Functionally and Molecularly Distinct Tumor-Initiating Cells in Human Glioblastoma Multiforme and Is Required for Gliomagenesis.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. KATAKOWSKI ME , Buller B, Wang X, Rogers T, et al
    Functional microRNA is transferred between glioma cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. BRUNCKHORST MK , Wang H, Lu R, Yu Q, et al
    Angiopoietin-4 Promotes Glioblastoma Progression by Enhancing Tumor Cell Viability and Angiogenesis.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
76. MOLINA JR , Morales FC, Hayashi Y, Aldape KD, et al
    Loss of PTEN Binding Adapter Protein NHERF1 from Plasma Membrane in Glioblastoma Contributes to PTEN Inactivation.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. GILBERT CA , Daou MC, Moser RP, Ross AH, et al
    {gamma}-Secretase Inhibitors Enhance Temozolomide Treatment of Human Gliomas by Inhibiting Neurosphere Repopulation and Xenograft Recurrence.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. ZHOU M , Wiemels JL, Bracci PM, Wrensch MR, et al
    Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. HADJIPANAYIS CG , Machaidze R, Kaluzova M, Wang L, et al
    EGFRvIII Antibody-Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery and Targeted Therapy of Glioblastoma.
    Cancer Res. 2010;70:6303-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
80. LADHA J , Donakonda S, Agrawal S, Thota B, et al
    Glioblastoma-Specific Protein Interaction Network Identifies PP1A and CSK21 as Connecting Molecules between Cell Cycle-Associated Genes.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. BELLODI C , Krasnykh O, Haynes N, Theodoropoulou M, et al
    Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis.
    Cancer Res. 2010;70:6026-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. SUN J , Masterman-Smith MD, Graham NA, Jiao J, et al
    A Microfluidic Platform for Systems Pathology: Multiparameter Single-Cell Signaling Measurements of Clinical Brain Tumor Specimens.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
83. HAAS BR , Sontheimer H
    Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 Reduces Glioma Invasion.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. WARRINGTON NM , Gianino SM, Jackson E, Goldhoff P, et al
    Cyclic AMP Suppression Is Sufficient to Induce Gliomagenesis in a Mouse Model of Neurofibromatosis-1.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. TRAN THANG NN , Derouazi M, Philippin G, Arcidiaco S, et al
    Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development.
    Cancer Res. 2010;70:4829-39.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. HEINE VM , Priller M, Ling J, Rowitch DH, et al
    Dexamethasone Destabilizes Nmyc to Inhibit the Growth of Hedgehog-Associated Medulloblastoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. MCELLIN B , Camacho CV, Mukherjee B, Hahm B, et al
    PTEN Loss Compromises Homologous Recombination Repair in Astrocytes: Implications for Glioblastoma Therapy with Temozolomide or Poly(ADP-Ribose) Polymerase Inhibitors.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. AYRAULT O , Zhao H, Zindy F, Qu C, et al
    Atoh1 Inhibits Neuronal Differentiation and Collaborates with Gli1 to Generate Medulloblastoma-Initiating Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
89. PANNER A , Crane CA, Weng C, Feletti A, et al
    Ubiquitin-Specific Protease 8 Links the PTEN-Akt-AIP4 Pathway to the Control of FLIPS Stability and TRAIL Sensitivity in Glioblastoma Multiforme.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. PRESTEGARDEN L , Svendsen A, Wang J, Sleire L, et al
    Glioma Cell Populations Grouped by Different Cell Type Markers Drive Brain Tumor Growth.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. YOON DJ , Kwan BH, Chao FC, Nicolaides TP, et al
    Intratumoral Therapy of Glioblastoma Multiforme Using Genetically Engineered Transferrin for Drug Delivery.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. CARCABOSO AM , Elmeliegy MA, Shen J, Juel SJ, et al
    Tyrosine Kinase Inhibitor Gefitinib Enhances Topotecan Penetration of Gliomas.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. WONG HK , Lahdenranta J, Kamoun WS, Chan AW, et al
    Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.
    Cancer Res. 2010;70:3483-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. BENDER AM , Collier LS, Rodriguez FJ, Tieu C, et al
    Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas.
    Cancer Res. 2010;70:3557-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
95. HATTERMANN K , Held-Feindt J, Lucius R, Muerkoster SS, et al
    The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. LIU L , Wu J, Ying Z, Chen B, et al
    Astrocyte Elevated Gene-1 Upregulates Matrix Metalloproteinase-9 and Induces Human Glioma Invasion.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. DAI B , Pieper RO, Li D, Wei P, et al
    FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes.
    Cancer Res. 2010;70:2951-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. WU X , Rauch TA, Zhong X, Bennett WP, et al
    CpG island hypermethylation in human astrocytomas.
    Cancer Res. 2010;70:2718-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
99. MICHAUD K , Solomon DA, Oermann E, Kim JS, et al
    Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
100. CHEN L , Iraci N, Gherardi S, Gamble LD, et al
     p53 is a direct transcriptional target of MYCN in neuroblastoma.
     Cancer Res. 2010;70:1377-88.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2010
101. SCHIFFMAN JD , Hodgson JG, VandenBerg SR, Flaherty P, et al
     Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.
     Cancer Res. 2010;70:512-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. CEROVAC V , Monteserin-Garcia J, Rubinfeld H, Buchfelder M, et al
     The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells.
     Cancer Res. 2010;70:666-74.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: